Robots move into care as COVID-19 reshapes Australian health

The COVID-19 pandemic accelerated robot adoption in hospitals and nursing homes as services sought to reduce unnecessary exposure, preserve scarce staff and keep care moving during visitor restrictions. Machines already used for UV-C disinfection and bed delivery became harder to ignore, while telepresence and assistive devices gained attention for virtual medical rounds, rehabilitation and social connection. Automation moved closer to the core of clinical operations rather than remaining a laboratory experiment.

Adoption has been uneven because the useful technology is often a bundle of machines, software and human procedures. Hospitals favour repeatable tasks with clear infection-control value, while aged-care operators face different needs involving supervision, mobility, family contact and resident dignity. Evidence is strongest for narrow jobs such as surface disinfection and transport, while fully autonomous care remains limited by safety, cost and the need for clinical accountability.

Australia provides a revealing setting for this shift. Sydney and Melbourne contain large hospital systems and residential aged-care operators able to test technologies across multiple sites, while Medicare-supported telehealth has made remote consultation routine. Local purchasing also reflects a split market: hospitals fund equipment through capital and infection-control budgets, whereas aged-care operators buy or lease through service agreements shaped by post-Royal Commission scrutiny. Privacy law, workplace standards and import rules determine whether a promising device can operate here.

Infection control turned automation into an operational priority

COVID-19 made contamination control an executive priority. Hospitals had to clean high-traffic areas rapidly, document repeated cleaning and reduce staff movement between infectious and non-infectious zones. Mobile UV-C units offered a measurable service because they could move through corridors, log treatment cycles and target spaces after routine cleaning. They still require correct dose, line-of-sight exposure and safe operation, so the machines support infection-control teams rather than replacing hand hygiene or terminal cleaning.

Workforce pressure strengthened the business case. Nurses and support staff spent time collecting supplies, moving equipment and performing repetitive cleaning that could expose them to pathogens. Mobile delivery robots reduced some corridor journeys, while remote-controlled machines allowed staff to inspect equipment without entering a room. The best deployments were selected around measurable workloads, not novelty. A robot that saves time but creates new charging, cleaning or maintenance work offers little operational value.

Remote care supplied another impetus. The rise in global telehealth adoption gave hospitals a ready-made channel for virtual specialists, remote monitoring and family consultations. Telepresence robots could bring a clinician, relative or priest into a quarantined room, reducing the number of people who had to enter. Their value depended on reliable connectivity, clear consent and a human operator who could control the device when something went wrong.

Hospitals and aged care need different operating models

Hospital demand concentrated in isolation rooms, emergency departments, intensive care units and pathology areas. Large hospital networks in Sydney and Melbourne had the volume and technical teams needed to integrate autonomous carts, UV-C systems and telepresence platforms with existing clinical software. These installations worked best when a robot’s route avoided sensitive spaces, its battery charging did not obstruct emergency traffic and infection-control staff could verify that every operating cycle met local procedures.

Residential aged care presented a more complicated environment. Australian nursing homes accommodate residents with differing mobility, cognition and medical needs in shared buildings rather than controlled clinical zones. During NSW visitor restrictions and Melbourne outbreaks, remote communication became especially valuable, but residents also depended on physical reassurance, touch and rapid human assistance. A robot that delivered a meal efficiently but frightened a resident with dementia could undermine the quality of care it was intended to protect.

The comparison matters because success measures differ. A hospital robot can be judged by staff exposure, delivery time and cleaning coverage, while an aged-care system may be judged by resident wellbeing, family access and the number of incidents requiring a quick response. Both require integration with building systems, identity controls and existing software. Australian buyers also need to consider local repair capacity, as a device unsupported by nearby technicians can remain idle when the national health system is already under pressure.

Aged care became a proving ground for responsible assistance

Residential aged care was among the first settings where the pandemic made automation visible to families. Telepresence carts allowed relatives and doctors to speak with residents without entering the facility, while autonomous delivery units carried meals, linens and routine items. In large Victorian and NSW operators, these systems helped maintain contact when outbreaks made visits impossible. They also highlighted the limits of remote connection: latency, unfamiliar interfaces and technical failures can exclude residents rather than include them.

Assistive robotics has since expanded to fall detection, walking support, reminders and social interaction. Australian aged-care operators are attracted by the potential to alert staff to risks and reduce repetitive supervision, particularly where staffing levels vary by shift and demand. The evidence remains mixed. Devices can be intrusive, inaccurate or infantilising, and sensors may create a false impression that a resident is safe because no alert has arrived. Procurement therefore benefits from demonstrations involving residents, families, clinicians and dementia advocacy groups.

Robotic assistance must sit within, rather than displace, broader clinical care. Age-related vitamin B12 deficiency can cause neurological symptoms that complicate mobility, fatigue and cognitive assessment. A robot that records wandering, inactivity or meal refusal cannot diagnose the cause. Dietitians, general practitioners and nurses still need to interpret observations and provide treatment, while any claimed benefit should be measured against the whole care workload.

Regulation privacy and supply chains determine safe deployment

The intended purpose of a robot determines how Australian regulators treat it. A transport cart may require limited scrutiny, while software that identifies a fall, recommends treatment or makes a clinical assessment can fall within the medical-device framework. Manufacturers may need evidence of safety and performance before inclusion in the Australian Register of Therapeutic Goods. Hospitals and aged-care operators should examine the intended use, vendor evidence and responsibilities for updates rather than treating all robotic products as equivalent.

Privacy protections become especially important when cameras, microphones, location sensors and voice recorders are combined. Covered organisations must apply the Australian Privacy Principles, determine whether consent is required and explain what data the system collects. Residents should receive plain-language information and retain choices where robot use is not essential to care. Vendors should also disclose data storage locations, retention periods and cybersecurity arrangements. Automated monitoring without a human response plan can create a false sense of security.

Neurological concerns add another reason for caution. Emerging evidence on brain inflammation and damage reinforces the need to avoid treating changes in walking, speech, sleep or confusion as simple signs of ageing. Post-COVID symptoms may require specialist assessment, and a sensor reading cannot substitute for that process. Robots can organise observations or prompt an appointment, but diagnostic claims need clinical evidence and appropriate regulatory oversight.

Importation and maintenance are equally practical issues. Machines purchased overseas may need clearance through Australian Customs, assessment under biosecurity legislation, TGA oversight and compliance with electrical safety and wireless equipment rules. Used equipment also needs documented cleaning, software support and access to spare parts. This has favoured service contracts and partnerships with Australian suppliers, integrators and technicians who can maintain systems across metropolitan and regional sites.

A measured rollout offers the strongest return

The strongest deployments begin with a service problem, a defined user and a baseline for comparison. A limited pilot can reveal whether a machine reduces exposure, improves response times or supports residents without adding work elsewhere. Contracts should cover training, cleaning, charging, software updates and downtime, because the purchase price represents only part of the cost. For smaller aged-care operators, leasing or shared regional services may offer a more realistic entry point than buying an entire fleet.

• Start with a clearly defined workflow problem, such as recurrent exposure during night-time specimen runs, rather than a preferred device.
• Map every hand-off from task completion to cleaning, charging, data handling and escalation so the robot does not create hidden work.
• Validate disinfection procedures with infection-control specialists and document how each machine complements manual cleaning.
• Involve nurses, residents, families, clinicians, IT staff and facilities teams before procurement, with accessible training and a named human fallback.
• Establish baseline measures for staff exposure time, time on task, response times, resident wellbeing, privacy incidents and total operating cost.
• Require consent and clear notices for cameras, voice recording and biometric monitoring, including choices to decline where care does not depend on the technology.
• Build servicing, cybersecurity, software-update and spare-parts obligations into tenders, weighing the value of local technical support.

Trials should run long enough to cover busy periods, equipment failures and staff turnover. A system that works when a specialist technician is on site but fails during ordinary weekend operations may not be suitable for routine care. Scaling should follow evidence, with independent evaluation where possible and procurement teams comparing outcomes rather than promotional claims. Australian operators can also use shared purchasing arrangements to spread training and maintenance costs across smaller facilities.

The pandemic accelerated the arrival of robots, but it also exposed where digital care succeeds and where human contact remains indispensable. Australian health services now have practical experience with telepresence, autonomous delivery and environmental disinfection, along with a clearer understanding of privacy, consent and workforce limitations. The institutions that achieve durable value will be those that define each machine’s task, limits and accountability before allowing it into care.